Price (delayed)
$28.57
Market cap
$2.19B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.74
Enterprise value
$1.98B
Veracyte is a global genomic diagnostics company that improves patient care by providing answers to clinical questions, informing diagnosis and treatment decisions throughout the patient journey in cancer and other
There are no recent dividends present for VCYT.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from and Sharadar.